Bcl-2 inhibitors enhance FGFR inhibitor-induced mitochondrial-dependent cell death in FGFR2-mutant endometrial cancer

Packer, LM; Stehbens, SJ; Bonazzi, VF; Gunter, JH; Ju, RJ; Ward, M; Gartside, MG; Byron, SA; Pollock, PM

Pollock, PM (reprint author), Queensland Univ Technol, Translat Res Inst, 37 Kent St, Woolloongabba, Qld 4102, Australia.

MOLECULAR ONCOLOGY, 2019; 13 (4): 738

Abstract

Endometrial cancer is the most commonly diagnosed gynaecological malignancy. Unfortunately, 15-20% of women demonstrate persistent or recurrent tumour......

Full Text Link